Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
RESEARCH TOOLSreports
Crinetics Pharmaceuticals (CRNX) Ownership - Who Owns Crinetics Pharmaceuticals?
416 Followers
Crinetics Pharmaceuticals (CRNX) Ownership Overview
9.71% Insiders
25.61% Mutual Funds
12.86% Other Institutional Investors
51.82% Public Companies and Individual Investors
The ownership structure of Crinetics Pharmaceuticals (CRNX) stock is a mix of institutional, retail and individual investors. Approximately 38.47% of the company’s stock is owned by Institutional Investors, 9.71% is owned by Insiders and 51.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 17, 2024 | Richard Scott Struthers President & Ceo,director | Bought | $38200 |
| Apr 02, 2024 | Stephanie Okey Director | Sold | $811650 |
| Apr 02, 2024 | Stephanie Okey Director | Bought | $320075 |
| Mar 26, 2024 | Sold | $1433675 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $1565 | |
| Dec 31, 2023 | Sold | $4372924 | |
| Dec 31, 2023 | Bought | $15686972 | |
| Dec 31, 2023 | Sold | $44671116 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,039,957 | Institution | 6.47% | 222,866,899 | |
| 3,381,851 | Institution | 4.34% | 149,545,451 | |
| 3,117,972 | Institution | 4.00% | 137,876,722 | |
| 2,820,943 | Institution | 3.62% | 124,742,099 | |
| 1,853,905 | Institution | 2.38% | 81,979,679 | |
| 1,566,200 | Institution | 2.01% | 69,257,364 | |
| 1,413,650 | Institution | 1.81% | 62,511,603 | |
| 1,329,330 | Institution | 1.71% | 58,782,973 | |
| 1,255,512 | Institution | 1.61% | 55,518,741 | |
| 1,141,633 | Institution | 1.46% | 50,483,011 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,820,943 | Institution | 3.62% | 124,742,099 | |
| 1,566,200 | Institution | 2.01% | 69,257,364 | |
| 1,413,650 | Institution | 1.81% | 62,511,603 | |
| 1,329,330 | Institution | 1.71% | 58,782,973 | |
| 1,141,633 | Institution | 1.46% | 50,483,011 | |
| 783,032 | Institution | 1.00% | 34,625,675 | |
| 717,930 | Institution | 0.92% | 31,746,865 | |
| 714,930 | Institution | 0.92% | 31,614,205 | |
| 679,078 | Institution | 0.87% | 30,028,829 | |
| 674,789 | Institution | 0.87% | 29,839,170 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,976,807 | Institution | 2.54% | 92,534,336 | |
| 1,775,297 | Institution | 2.28% | 78,503,633 | |
| 1,557,059 | Institution | 2.00% | 68,853,149 | |
| 867,242 | Institution | 1.11% | 40,595,598 | |
| 535,646 | Institution | 0.69% | 23,686,266 | |
| 508,997 | Institution | 0.65% | 22,507,847 | |
| 275,641 | Institution | 0.35% | 12,188,845 | |
| 246,393 | Institution | 0.32% | 11,533,656 | |
| 218,229 | Institution | 0.28% | 10,215,299 | |
| 143,081 | Institution | 0.18% | 6,327,042 |
FAQ
Who Owns Crinetics Pharmaceuticals (CRNX)?
According to the latest TipRanks data, approximately 12.86% of the company's stock is held by institutional investors, 9.71% is held by insiders, and 51.82% is held by retail investors.
What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.86% of Crinetics Pharmaceuticals (CRNX) stock is held by institutional investors.
What percentage of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.82% of Crinetics Pharmaceuticals (CRNX) stock is held by retail investors.
Who owns the most shares of Crinetics Pharmaceuticals (CRNX)?
Richard Driehaus owns the most shares of Crinetics Pharmaceuticals (CRNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.